Results 331 to 340 of about 234,679 (371)

Cost Effectiveness of Left Ventricular Assist Devices (LVADs) as Destination Therapy: A Systematic Review. [PDF]

open access: yesPharmacoecon Open
Saygın Avşar T   +8 more
europepmc   +1 more source

Outcomes of prolonged support on surgically implanted microaxial left ventricular assist devices for refractory cardiogenic shock. [PDF]

open access: yesJTCVS Open
Feng I   +10 more
europepmc   +1 more source

Epidemiology and impact of device-specific infections on patients receiving left ventricular assist devices. [PDF]

open access: yesJHLT Open
Iyengar A   +17 more
europepmc   +1 more source

Ventricular Assist Devices

Cardiac Anesthesia: A Problem-Based Learning Approach, 2019
Left ventricular assist devices (LVADs) have found increasing use since their initial approval in 1994. They can be used as bridge therapy to heart transplantation or as destination therapy for patients in whom transplants are not possible.
K. Togashi
semanticscholar   +2 more sources

Electromagnetic interference from left ventricular assist devices in patients with subcutaneous implantable cardioverter‐defibrillators

Cardiovascular Electrophysiology, 2020
Interactions of left ventricular assist devices (LVADs) with transvenous implantable cardioverter‐defibrillator systems (ICDs) have been widely reported.
Yuji Ishida   +3 more
semanticscholar   +1 more source

Ventricular assist devices

Current Opinion in Anaesthesiology, 2003
Recent advances in technology as well as new indications for implantation have appeared in the field of ventricular assist devices. Progress has also been made in the understanding of the underlying mechanisms of myocardial recovery after ventricular assist device support.Technological progress includes the development of fully implantable pulsatile ...
Edith, Collard   +2 more
openaire   +2 more sources

Ventricular Assist Device Infections

Current Infectious Disease Reports, 2012
Ventricular Assist Devices(VAD) are the commonest form of cardiac mechanical support, used as bridge to transplantation but also as destination therapy in non-transplant-eligible patients in whom transplantation is considered unsuitable based on age criteria. Infections are common and can significantly impact on patient outcome.
Denis, Spelman, Donald, Esmore
openaire   +2 more sources

Home - About - Disclaimer - Privacy